Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion type Assertion NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_head.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion description "[It was hypothesised that effective and selective delivery of RRM1 siRNA will help in the treatment of lung cancer chemotherapy using Gemcitabine hydrochloride by reducing drug dose and thereby, reduces dose related toxicity of Gemcitabine hydrochloride.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_provenance.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion evidence source_evidence_literature NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_provenance.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion SIO_000772 24792823 NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_provenance.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion wasDerivedFrom befree-2016 NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_provenance.
- NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_assertion wasGeneratedBy ECO_0000203 NP1179052.RAXzbu6PfyvJ6JoXcO2W_pwP3bTWWbcECh9C5gHhC-ICI130_provenance.